Searched for
LUPIN ACQUISITION
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...- Lupin subsidiary inks pact to acquire Netherlands-based VISUfarmaLupin's subsidiary will acquire VISUfarma BV for 190 million euros. This expands Lupin's European business and eye health product range. Th...
- Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 crLupin has acquired a portfolio of established products in Europe and Canada from Sanofi for a purchase consideration of EUR 10 million. The...
- Lupin to acquire French firm Medisol for around Rs 160 crPharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160...
- Lupin Q3 Results: Profit slumps 72% to Rs 153 crDrug maker Lupin has reported 72 per cent decline in consolidated net profit at Rs 153 crore for the third quarter ended December 31, 2022....
- Lupin completes acquisition of portfolio of brands from Anglo-French Drugs & Industries"India is critical in shaping Lupin's growth story going forward. This acquisition strengthens our position in the Indian market, where we ...
- Lupin CFO quits, to pursue opportunities outside pharmaSwaminathan as the CFO of Lupin, was part of some of company's biggest mergers and acquisition in US and Japan
- Lupin gains on Symbiomix Therapeutics acquisitionThe scrip touched its fresh 52-week high of Rs 1,572.25 on February 6, 2017 and its 52-week low of Rs 920 on August 21, 2017.
- Lupin's US arm takes over Symbiomix TherapeuticsLupin had entered into an arrangement to acquire the company earlier this year.
- Stock pick of the week: Why analysts are bullish on LupinIn addition to growth in sales in respective markets, favourable currency movement has also helped Lupin to achieve high growth.
- Lupin completes acquisition of GAVIS PharmaThe acquisition enhances the company's scale in the US generic market and also broadens its pipeline in dermatology and controlled substanc...
- Buyouts unlikely to harm debt-free Lupin's healthWith no new blockbuster drugs going off patent in the near term, generic pharma companies have to explore new areas of growth like specialt...
- Lupin acquires Brazilian branded generics firm MedquímicaMedquimica recorded net revenues of approximately BRL 94 million (~ $31 million) in calendar year 2014 and has over 550 employees.
- Lupin acquires Brazilian drug firm MedquimicaThe company has acquired 100 per cent equity stake in Medquimica Industria Farmaceutica subject to certain closing conditions.
- Lupin scouts for acquisitions in USCompany continues to be on the lookout for meaningful targets, be it brands or technology companies, in inhalation, complex injectables and...
- Scouting for global acquisitions of brands, companies: LupinThe Mumbai-based firm is adopting a three-pronged approach in its acquisition strategy, which also includes the domestic market.
- Lupin to replicate Japan model for expansion in various marketsLupin recently enhanced its presence in Japan with the acquisition of I'rom Pharmaceuticals in November this year for an undisclosed amount.
- Lupin scouts for buys in Latin AmericaThe company expects to launch 10 new products in Japan this year, considered the most difficult of three developed pharmaceutical markets -...
- Lupin targets buys in Gulf, Mexico, Brazil and ArgentinaLupin Ltd. continues its buying spree with planned acquisitions in Gulf, Mexico, Brazil and Argentina.
- Lupin looks for acquisitions abroadPharma company Lupin is looking at acquisitions abroad for its expansion plans this fiscal and has raised US$ 100 million for the purpose.
Load More
